SCHEMBL4217232

SCHEMBL4217232

O=C(O)c1ccc(CCc2ccccc2)cc1NCCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 3/20 0.61
KDM4C Q9H3R0 3/20 0.61
KDM4E B2RXH2 5/20 0.58
ASPH Q12797 4/20 0.58
KDM8 Q8N371 4/20 0.58
RIOX2 Q8IUF8 3/20 0.58
MAPT P10636 3/20 0.56
MCL1 Q07820 1/20 0.49
BCL2A1 Q16548 1/20 0.49
MEN1 O00255 2/20 0.49
BLM P54132 2/20 0.49
KMT2A Q03164 2/20 0.49
RECQL P46063 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
EGLN1 Q9GZT9 1/20 0.48
ALDH1A1 P00352 3/20 0.47
HSD17B10 Q99714 3/20 0.47
HPGD P15428 2/20 0.47
HTR6 P50406 1/20 0.47
CDK2 P24941 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4212950 0.88 ALDH1A1 (0.59) KDM6BKDM4CKDM4EASPHKDM8
SCHEMBL1116010 0.86 KDM6B (0.59) KDM6BKDM4CKDM4EASPHKDM8
SCHEMBL22836946 0.85 KDM6B (0.58) KDM6BKDM4CKDM4EASPHKDM8
Enfenamic Acid SCHEMBL25191 0.83 KDM6B (0.68) KDM6BKDM4CKDM4EASPHKDM8
Enfenamic Acid SCHEMBL10935569 0.82 KDM6B (0.66) KDM6BKDM4CKDM4EASPHKDM8
SCHEMBL4221921 0.81 ALDH1A1 (0.52) KDM6BKDM4CKDM4EASPHKDM8
SCHEMBL4223020 0.81 MEN1 (0.63) MAPTMEN1BLMKMT2ARECQL
SCHEMBL8107946 0.80 MEN1 (0.48) KDM6BKDM4CKDM4EASPHKDM8
SCHEMBL4217437 0.79 RECQL (0.43) KDM6BKDM4CKDM4EASPHKDM8
SCHEMBL4217443 0.79 RECQL (0.43) KDM6BKDM4CKDM4EASPHKDM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
EP-1860098-B1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-14 EP disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 KDM6B 2594/4885KDM4C 1892/4885KDM4E 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.